目的 在肿瘤患者群体中评价中文版患者报告结局测量信息系统(patient-reported outcomes measure-ment information system，PROMIS)疼痛干扰4a简表的测量学指标。方法 于2021年12月-2022年1月，使用PROMIS疼痛干扰4a简表在复旦大学附属肿瘤医院采用方便抽样法调研收集肿瘤患者资料，采用Mplus 8。3软件及SPSS 20。0软件分析量表及条目的地板效应、天花板效应;分析量表的结构效度、效标关联效度和信度等测量性能;并初步进行量表的测量等价性检验。结果 最终纳入240例肿瘤患者。中文版PROMIS疼痛干扰4a简表在肿瘤患者群体中的Cronbach'sα系数为0。961，信度较好。验证性因子分析提示模型拟合较好。量表评分与中文版欧洲癌症研究中心(EORTC)生命品质评估量表(Quality of life questionnaire。core 30，QLO-C30))(v3。0)疼痛维度呈显著正相关(P＜0。01)，效标关联效度较好。癌症早期和晚期患者疼痛干扰得分差异具有统计学意义(P＜0。05)，提示已知组别效度良好。量表条目评分最低1分的患者比例大于20％，提示存在明显的地板效应。结论 中文版PROMIS疼痛干扰4a简表在肿瘤患者中的测量学性能总体较好，适用于国内肿瘤患者人群。但今后还需对部分性能进一步检验和调试。
The psychometric test of Chinese version-PROMIS pain interference short form among patients with cancer
Objective To evaluate the psychometric properties of Chinese version-patient-reported outcomes meas-urement information system(PROMIS)pain interference short form 4a among patients with cancer.Methods The da-ta of cancer patients in the Fudan University Shanghai Cancer Center was collected by PROMIS pain interference short form,and Mplus 8.3 software and SPSS 20.0 software were used to analyze the floor effect and ceiling effect of the scales and items,and to measure the structure validity,criterion association validity,and reliability of the scale,and the measurement equivalence was preliminarily evaluated.Results A total of 240 cancer patients were fi-nally comprised for data analysis.The Cronbach's α coefficient of the Chinese version-PROMIS pain interference short form was 0.961 in patients with cancer,indicating good reliability.The results of confirmatory factor analysis suggested that the model fitted well.There was a significant positive correlation between the short form and the Chi-nese version-EORTC QLQ-C30(v3.0)pain dimension(P＜0.01),indicating good concurrent validity.The differ-ence of pain interference score between early and later cancer patients was statistically significant(P＜0.05),sug-gesting good known-groups validity.The proportion of patients with the lowest item score of 1 in the scale was grea-ter than 20％,indicating the existence of significant floor effect.Conclusions The Chinese version-PROMIS pain in-terference short form 4a has good overall measurement performance in cancer patients,and is suitable for domestic cancer patients.However,it is necessary to further test and debug some performance in the future.
cancerpatient-reported outcomespain interferencepsychometric test
万方数据
维普
